Collegium Pharmaceutical Inc (COLL)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 1,663,590 | 1,143,310 | 1,174,130 | 692,077 | 643,841 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,663,590K
= 0.00
The debt-to-assets ratio for Collegium Pharmaceutical Inc has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are fully funded by equity rather than debt, which may indicate a strong financial position and lower financial risk. However, it's important to note that a low debt-to-assets ratio may also imply limited leveraging potential for potential growth or expansion opportunities.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Collegium Pharmaceutical Inc
COLL
0.00
Abbott Laboratories
ABT
0.00
AbbVie Inc
ABBV
0.00
ACADIA Pharmaceuticals Inc
ACAD
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
ANI Pharmaceuticals Inc
ANIP
0.00
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalyst Pharmaceuticals Inc
CPRX
0.00